Mutational analysis of Aedes aegypti Dicer 2 provides insights into the biogenesis of antiviral exogenous small interfering RNAs.

The exogenous small interfering RNA (exo-siRNA) pathway is a key antiviral mechanism in the Aedes aegypti mosquito, a widely distributed vector of human-pathogenic arboviruses. This pathway is induced by virus-derived double-stranded RNAs (dsRNA) that are cleaved by the ribonuclease Dicer 2 (Dcr2) i...

Full description

Bibliographic Details
Main Authors: Rommel J Gestuveo, Rhys Parry, Laura B Dickson, Sebastian Lequime, Vattipally B Sreenu, Matthew J Arnold, Alexander A Khromykh, Esther Schnettler, Louis Lambrechts, Margus Varjak, Alain Kohl
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-01-01
Series:PLoS Pathogens
Online Access:https://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1010202&type=printable
_version_ 1826552595173343232
author Rommel J Gestuveo
Rhys Parry
Laura B Dickson
Sebastian Lequime
Vattipally B Sreenu
Matthew J Arnold
Alexander A Khromykh
Esther Schnettler
Louis Lambrechts
Margus Varjak
Alain Kohl
author_facet Rommel J Gestuveo
Rhys Parry
Laura B Dickson
Sebastian Lequime
Vattipally B Sreenu
Matthew J Arnold
Alexander A Khromykh
Esther Schnettler
Louis Lambrechts
Margus Varjak
Alain Kohl
author_sort Rommel J Gestuveo
collection DOAJ
description The exogenous small interfering RNA (exo-siRNA) pathway is a key antiviral mechanism in the Aedes aegypti mosquito, a widely distributed vector of human-pathogenic arboviruses. This pathway is induced by virus-derived double-stranded RNAs (dsRNA) that are cleaved by the ribonuclease Dicer 2 (Dcr2) into predominantly 21 nucleotide (nt) virus-derived small interfering RNAs (vsiRNAs). These vsiRNAs are used by the effector protein Argonaute 2 within the RNA-induced silencing complex to cleave target viral RNA. Dcr2 contains several domains crucial for its activities, including helicase and RNase III domains. In Drosophila melanogaster Dcr2, the helicase domain has been associated with binding to dsRNA with blunt-ended termini and a processive siRNA production mechanism, while the platform-PAZ domains bind dsRNA with 3' overhangs and subsequent distributive siRNA production. Here we analyzed the contributions of the helicase and RNase III domains in Ae. aegypti Dcr2 to antiviral activity and to the exo-siRNA pathway. Conserved amino acids in the helicase and RNase III domains were identified to investigate Dcr2 antiviral activity in an Ae. aegypti-derived Dcr2 knockout cell line by reporter assays and infection with mosquito-borne Semliki Forest virus (Togaviridae, Alphavirus). Functionally relevant amino acids were found to be conserved in haplotype Dcr2 sequences from field-derived Ae. aegypti across different continents. The helicase and RNase III domains were critical for silencing activity and 21 nt vsiRNA production, with RNase III domain activity alone determined to be insufficient for antiviral activity. Analysis of 21 nt vsiRNA sequences (produced by functional Dcr2) to assess the distribution and phasing along the viral genome revealed diverse yet highly consistent vsiRNA pools, with predominantly short or long sequence overlaps including 19 nt overlaps (the latter representing most likely true Dcr2 cleavage products). Combined with the importance of the Dcr2 helicase domain, this suggests that the majority of 21 nt vsiRNAs originate by processive cleavage. This study sheds new light on Ae. aegypti Dcr2 functions and properties in this important arbovirus vector species.
first_indexed 2024-12-13T12:48:41Z
format Article
id doaj.art-41a89ffe5db141d2b8a4ce811fe4b539
institution Directory Open Access Journal
issn 1553-7366
1553-7374
language English
last_indexed 2025-03-14T07:11:37Z
publishDate 2022-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Pathogens
spelling doaj.art-41a89ffe5db141d2b8a4ce811fe4b5392025-03-04T05:31:10ZengPublic Library of Science (PLoS)PLoS Pathogens1553-73661553-73742022-01-01181e101020210.1371/journal.ppat.1010202Mutational analysis of Aedes aegypti Dicer 2 provides insights into the biogenesis of antiviral exogenous small interfering RNAs.Rommel J GestuveoRhys ParryLaura B DicksonSebastian LequimeVattipally B SreenuMatthew J ArnoldAlexander A KhromykhEsther SchnettlerLouis LambrechtsMargus VarjakAlain KohlThe exogenous small interfering RNA (exo-siRNA) pathway is a key antiviral mechanism in the Aedes aegypti mosquito, a widely distributed vector of human-pathogenic arboviruses. This pathway is induced by virus-derived double-stranded RNAs (dsRNA) that are cleaved by the ribonuclease Dicer 2 (Dcr2) into predominantly 21 nucleotide (nt) virus-derived small interfering RNAs (vsiRNAs). These vsiRNAs are used by the effector protein Argonaute 2 within the RNA-induced silencing complex to cleave target viral RNA. Dcr2 contains several domains crucial for its activities, including helicase and RNase III domains. In Drosophila melanogaster Dcr2, the helicase domain has been associated with binding to dsRNA with blunt-ended termini and a processive siRNA production mechanism, while the platform-PAZ domains bind dsRNA with 3' overhangs and subsequent distributive siRNA production. Here we analyzed the contributions of the helicase and RNase III domains in Ae. aegypti Dcr2 to antiviral activity and to the exo-siRNA pathway. Conserved amino acids in the helicase and RNase III domains were identified to investigate Dcr2 antiviral activity in an Ae. aegypti-derived Dcr2 knockout cell line by reporter assays and infection with mosquito-borne Semliki Forest virus (Togaviridae, Alphavirus). Functionally relevant amino acids were found to be conserved in haplotype Dcr2 sequences from field-derived Ae. aegypti across different continents. The helicase and RNase III domains were critical for silencing activity and 21 nt vsiRNA production, with RNase III domain activity alone determined to be insufficient for antiviral activity. Analysis of 21 nt vsiRNA sequences (produced by functional Dcr2) to assess the distribution and phasing along the viral genome revealed diverse yet highly consistent vsiRNA pools, with predominantly short or long sequence overlaps including 19 nt overlaps (the latter representing most likely true Dcr2 cleavage products). Combined with the importance of the Dcr2 helicase domain, this suggests that the majority of 21 nt vsiRNAs originate by processive cleavage. This study sheds new light on Ae. aegypti Dcr2 functions and properties in this important arbovirus vector species.https://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1010202&type=printable
spellingShingle Rommel J Gestuveo
Rhys Parry
Laura B Dickson
Sebastian Lequime
Vattipally B Sreenu
Matthew J Arnold
Alexander A Khromykh
Esther Schnettler
Louis Lambrechts
Margus Varjak
Alain Kohl
Mutational analysis of Aedes aegypti Dicer 2 provides insights into the biogenesis of antiviral exogenous small interfering RNAs.
PLoS Pathogens
title Mutational analysis of Aedes aegypti Dicer 2 provides insights into the biogenesis of antiviral exogenous small interfering RNAs.
title_full Mutational analysis of Aedes aegypti Dicer 2 provides insights into the biogenesis of antiviral exogenous small interfering RNAs.
title_fullStr Mutational analysis of Aedes aegypti Dicer 2 provides insights into the biogenesis of antiviral exogenous small interfering RNAs.
title_full_unstemmed Mutational analysis of Aedes aegypti Dicer 2 provides insights into the biogenesis of antiviral exogenous small interfering RNAs.
title_short Mutational analysis of Aedes aegypti Dicer 2 provides insights into the biogenesis of antiviral exogenous small interfering RNAs.
title_sort mutational analysis of aedes aegypti dicer 2 provides insights into the biogenesis of antiviral exogenous small interfering rnas
url https://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1010202&type=printable
work_keys_str_mv AT rommeljgestuveo mutationalanalysisofaedesaegyptidicer2providesinsightsintothebiogenesisofantiviralexogenoussmallinterferingrnas
AT rhysparry mutationalanalysisofaedesaegyptidicer2providesinsightsintothebiogenesisofantiviralexogenoussmallinterferingrnas
AT laurabdickson mutationalanalysisofaedesaegyptidicer2providesinsightsintothebiogenesisofantiviralexogenoussmallinterferingrnas
AT sebastianlequime mutationalanalysisofaedesaegyptidicer2providesinsightsintothebiogenesisofantiviralexogenoussmallinterferingrnas
AT vattipallybsreenu mutationalanalysisofaedesaegyptidicer2providesinsightsintothebiogenesisofantiviralexogenoussmallinterferingrnas
AT matthewjarnold mutationalanalysisofaedesaegyptidicer2providesinsightsintothebiogenesisofantiviralexogenoussmallinterferingrnas
AT alexanderakhromykh mutationalanalysisofaedesaegyptidicer2providesinsightsintothebiogenesisofantiviralexogenoussmallinterferingrnas
AT estherschnettler mutationalanalysisofaedesaegyptidicer2providesinsightsintothebiogenesisofantiviralexogenoussmallinterferingrnas
AT louislambrechts mutationalanalysisofaedesaegyptidicer2providesinsightsintothebiogenesisofantiviralexogenoussmallinterferingrnas
AT margusvarjak mutationalanalysisofaedesaegyptidicer2providesinsightsintothebiogenesisofantiviralexogenoussmallinterferingrnas
AT alainkohl mutationalanalysisofaedesaegyptidicer2providesinsightsintothebiogenesisofantiviralexogenoussmallinterferingrnas